Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results

Journal:

Nature Medicine

Published:

2025-08-11

DOI:

10.1038/s41591-025-03876-4

Affiliations:

9

Authors:

15

Go to article

Institutions	Authors	Share
Elicio Therapeutics Inc., United States of America (USA)	6.000000	0.40
The University of Iowa (UI), United States of America (USA)	2.000000	0.13
University of California, Los Angeles (UCLA), United States of America (USA)	1.000000	0.07
Massachusetts General Hospital (MGH), United States of America (USA)	1.000000	0.07
Northwell Health, United States of America (USA)	1.000000	0.07
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)	1.000000	0.07
City of Hope, United States of America (USA)	1.000000	0.07
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.07
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	1.000000	0.07

Interested in Oncology and Carcinogenesis?